Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Uterine Cervical Neoplasms 81Endometrial Neoplasms 22Ovarian Neoplasms 12Vaginal Neoplasms 11Vulvar Neoplasms 10Neoplasms 8Sarcoma 6Carcinoma, Ovarian Epithelial 5Pelvic Neoplasms 4Fallopian Tube Neoplasms 4Wilms Tumor 3Urinary Bladder Neoplasms 3Testicular Neoplasms 3Prostatic Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Locally Advanced Cervical Cancer 3Endometrial Clear Cell Adenocarcinoma 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Breast Neoplasms 3Anus Neoplasms 3Uterine Neoplasms 2Teratoma 2Sezary Syndrome 2Sarcoma, Endometrial Stromal 2Recurrence 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pheochromocytoma 2Penile Neoplasms 2

Interventions

Radiotherapy 2TP protocol 1Paclitaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × Radiotherapy × Gynecologic × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
36 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡